EXAS vs PECO · rev $2.76B vs P/E 45, rev $380.4M
EXACT Sciences Corporation (EXAS) versus Phillips Edison & Co Inc (PECO) — a side-by-side from cached financials, not a winner call.
EXACT Sciences Corporation (EXAS) is a diagnostics & research company listed on NASDAQ.
Phillips Edison & Co Inc (PECO) is a reit - retail company listed on NASDAQ.
Latest reported EXAS revenue for 2024-12-31 was $2.76B. Net income was -$1.03B. Revenue was up 10.4% from 2023-12-31 to 2024-12-31. EXAS currently screens at market cap $20.03B.
Latest reported PECO revenue for 2026-06-30 was $380.4M. Net income was $71.5M. Revenue was up 99.4% from 2026-03-31 to 2026-06-30. PECO currently screens at market cap $5.75B and trailing P/E 45.1.
EXAS currently screens at market cap $20.03B. PECO currently screens at market cap $5.75B and trailing P/E 45.1.
Not investment advice. Open the EXAS and PECO stock pages for the full models.
Not investment advice.